TerminatedNot applicableNCT01026909
Intraarticular Corticosteroid Therapy in Perthes Disease.
Studying Legg-Calvé-Perthes disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Seattle Children's Hospital
- Principal Investigator
- Klane K White, MD, M.DSeattle Children's Hospital
- Intervention
- Aristospan 20mg(drug)
- Enrollment
- 3 enrolled
- Eligibility
- 4-13 years · All sexes
- Timeline
- 2009 – 2014
Study locations (1)
- Seattle Children's Hospital, Seattle, Washington, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01026909 on ClinicalTrials.govOther trials for Legg-Calvé-Perthes disease
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNANCT07122323Robotic Arm-assisted THA Vs. Conventional THA in Legg-Calvé-Perthes DiseaseSecond Affiliated Hospital, School of Medicine, Zhejiang University
- RECRUITINGNCT05734651PROMIS Evaluation StudyBezirkskrankenhaus St. Johann in Tirol
- ACTIVE NOT RECRUITINGNCT03885960Perthes Disease in NorwayOslo University Hospital
- ENROLLING BY INVITATIONNCT02040714Multicenter Prospective Cohort Study on Current Treatments of Legg-Calvé-Perthes DiseaseTexas Scottish Rite Hospital for Children